Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease

Clinical Cardiology

Volumn 40, Issue 10, 2017, Pages 797-806

  Sorbets, Emmanuel ^a,b,c,d   Greenlaw, Nicola ^e   Ferrari, Roberto ^f,g   Ford, Ian ^e   Fox, Kim M ^h   Tardif, Jean Claude ⁱ   Tendera, Michal ^j   Steg, Philippe Gabriel ^a,b,c,h  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BICHAT HOSPITAL   (France)

^c University Paris VII   (France)

^d UNIVERSITÉ PARIS 13   (France)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f UNIVERSITY OF FERRARA   (Italy)

^g MARIA CECILIA HOSPITAL   (Italy)

^h ROYAL BROMPTON HOSPITAL   (United Kingdom)

ⁱ MONTREAL HEART INSTITUTE   (Canada)

^j MEDICAL UNIVERSITY OF SILESIA   (Poland)

more..

Author keywords

Baseline Characteristics; CLARIFY Registry; Stable Coronary Artery Disease

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE REGISTRY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTPATIENT; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; STUDY DESIGN; AFRICA; AGED; ASIA; AUSTRALIA; CARIBBEAN ISLANDS; CLINICAL TRIAL; COMORBIDITY; DIAGNOSTIC IMAGING; EUROPE; HEALTH STATUS; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; NORTH AMERICA; PROSPECTIVE STUDY; REGISTER; SOCIOECONOMICS; SOUTH AMERICA; TIME FACTOR; TREATMENT OUTCOME;

AFRICA; AGED; ASIA; AUSTRALIA; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; EUROPE; FEMALE; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NORTH AMERICA; OUTPATIENTS; PROSPECTIVE STUDIES; REGISTRIES; RESEARCH DESIGN; SOCIOECONOMIC FACTORS; SOUTH AMERICA; TIME FACTORS; TREATMENT OUTCOME; WEST INDIES;

EID: 85020008017     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22730     Document Type: Article

References (33)

1. Leal J, Luengo-Fernández R, Gray A, et al. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J. 2006;27:1610–1619.
2. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747–1757.
3. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet. 1997;349:1498–1504.
4. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet. 1999;353:1547–1557.
5. Daly CA, Clemens F, López-Sendón J, et al; Euro Heart Survey Investigators. The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable Angina. Eur Heart J. 2005;26:996–1010.
6. GRACE Investigators. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J. 2001;141:190–199.
7. Puymirat E, Simon T, Steg PG, et al; USIK USIC 2000 Investigators; FAST-MI Investigators. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA. 2012;308:998–1006.
8. Carrero JJ, Evans M, Szummer K, et al. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation. JAMA. 2014;311:919–928.
9. Zarifis J, Kallistratos M, Katsivas A, et al. Antianginal efficacy of ivabradine/metoprolol combination in patients with stable angina. Clin Cardiol. 2016;39:697–702.
10. Diaz A, Bourassa MG, Guertin MC, et al. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J. 2005;26:967–974.
11. Fox K, Ford I, Steg PG, et al; BEAUTIFUL Investigators. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet. 2008;372:817–821.
12. Fox K, Borer JS, Camm AJ, et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol. 2007;50:823–830.
13. Hsia J, Larson JC, Ockene JK, et al. Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study. BMJ. 2009;338:b219.
14. Kolloch R, Legler UF, Champion A, et al. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the International Verapamil-SR/trandolapril Study (INVEST). Eur Heart J. 2008;29:1327–1334.
15. Mauri L. Why we still need randomized trials to compare effectiveness. N Engl J Med. 2012;366:1538–1540.
16. Steg PG, López-Sendón J, Lopez de Sa E, et al. External validity of clinical trials in acute myocardial infarction. Arch Intern Med. 2007;167:68–73.
17. Steg PG, Bhatt DL, Wilson PW, et al; REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297:1197–1206.
18. Bhatt DL, Eagle KA, Ohman EM, et al; REACH Registry Investigators. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA. 2010;304:1350–1357.
19. Steg PG, James SK, Atar D, et al; Task Force on the Management of ST-segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–2619.
20. Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267–315.
21. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60:e44–e164.
22. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007;116:e148–e304.
23. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [published correction appears in J Am Coll Cardiol. 2013;62:1039]. J Am Coll Cardiol. 2013;61:485–510.
24. Ferrari R, Ford I, Greenlaw N, et al; CLARIFY Registry Investigators. Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: data from the contemporary CLARIFY registry. Eur J Prev Cardiol. 2015;22:1056–1065.
25. Vidal-Petiot E, Ford I, Greenlaw N, et al; CLARIFY Investigators. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study. Lancet. 2016;388:2142–2152.
26. Steg PG, Ferrari R, Ford I, et al; CLARIFY Investigators. Heart rate and use of β-blockers in stable outpatients with coronary artery disease. PLoS One. 2012;7:e36284.
27. Ferrari R, Abergel H, Ford I, et al; CLARIFY Investigators. Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease. Int J Cardiol. 2013;167:2938–2943.
28. Steg PG, Greenlaw N, Tardif JC, et al; CLARIFY Registry Investigators. Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. Eur Heart J. 2012;33:2831–2840.
29. Kalra PR, García-Moll X, Zamorano J, et al. Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22 272 patients. PLoS One. 2014;9:e102335.
30. Fauchier L, Greenlaw N, Ferrari R, et al; CLARIFY Investigators. Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY Registry. PLoS One. 2015;10:e0125164.
31. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–2962.
32. Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016;68:1082–1115.
33. Steg PG, Greenlaw N, Tendera M, et al. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry. JAMA Intern Med. 2014;174:1651–1659.